Kentucky Lung Cancer Screening Learning Collaborative

QUILS logoky-leads-collaborativeKentucky Lung Cancer Screening Learning Collaborative: Achieving Equity is organized by UK HealthCare and led by the Kentucky Lung Cancer Education Awareness Detection Survivorship (KY LEADSTM) Prevention and Early Detection team and the Quality Implementation of Lung Cancer Screening (QUILSTM) system. 

Spearheaded by Drs. Jennifer Redmond Knight and Timothy Mullett at the University of Kentucky and Dr. Jamie Studts at the University of Colorado, this series focuses on the equitable implementation of lung cancer screening in our communities.

Through our collaboration, we bring together medical professionals, members of community groups and state-based organizations that focus on lung cancer screening. We host interactive learning sessions where experts present resources to improve equity and optimize screening practice across the Commonwealth. Participation is free.


The collaborative meets for one hour per month from January to June 2023 via zoom.

New participants are welcome to join upcoming sessions.

Meetings include:

  • Educational sessions
  • Best practice overviews
  • Interactive trainings on tools and resources
  • Group discussions and problem-solving



  • Lung cancer screening program team members, including:
    • Administrators, leaders and medical doctors
    • Navigators and coordinators
    • Radiologists and radiology technicians
    • Pulmonolgists
    • Cardiothoracic surgeons
    • Nurses
    • Social workers
  • Primary care physicians and referring clinicians
  • Representatives of state agencies
  • Members of community-based organizations
  • Other partners in supporting lung cancer screening equity

We want to learn more about you so that we can provide high-quality content throughout the learning collaborative. You will be asked to complete a brief survey with your registration.

Once the survey is completed, you are automatically registered for all dates of the Lung Cancer Screening Collaborative Series.

Jan. 26: QUILS (Quality Implementation Lung Cancer Screening) and Equitable LCS (Lung Cancer Screening) 
Presented by Jamie Studts, PhD, FSBM, Jennifer Redmond Knight, DrPH, and Lovoria Williams, PhD, RN, FAAN
Zoom recording

Feb. 23: Equity and Multidisciplinary Components
Presented by Timothy Mullett, MD, MBA, FACS
Zoom recording

March 30: Equity and Lung Cancer Risk Reduction 
Presented by Jennifer Redmond Knight, DrPH, and Jessica Burris, PhD
Noon to 1 p.m. EST 

April 11: Equity and Candidate/Participant Engagement
Presented by Jamie Studts, PhD, FSBM
Noon to 1 p.m. EST

May 11: Equity and Leveraging Community Partnerships and Outreach Strategies to Increase Lung Cancer Screening Uptake
Presented by Lovoria Williams, PhD, RN, FAAN, Jennifer Redmond Knight, DrPH, and Pamela Hull, PhD
Noon to 1 p.m. EST

June 22: Conclusion and Next Steps
Presented by Timothy Mullett, MD, MBA, FACS, and all who can join
Noon to 1 p.m. EST

jamie studts

Jamie Studts, PhD, FSBM
Professor of Medical Oncology, Scientific Director of Behavioral Oncology, University of Colorado School of Medicine

jennifer redmon knight
Jennifer Redmond Knight, DrPH

Assistant Professor, Health Management & Policy, College of Public Health, University of Kentucky

lovoria williams
Lovoria Williams, PhD, RN, FAAN
Associate Director, Cancer Health Equity, Diversity and Inclusion, Markey Cancer Center, University of Kentucky 

tim mullett
Timothy Mullett, MD, MBA, FACS

Medical Director, Markey Cancer Center Network Development, Professor of Thoracic Surgery, Markey Cancer Center, University of Kentucky

jessica burris
Jessica Burris, PhD

Associate Professor and Associate Chair, Department of Psychology, University of Kentucky 

pamela hull
Pamela Hull, PhD

Associate Director of Population Science and Community Impact, Markey Cancer Center, University of Kentucky 

allyson yates

Allyson Yates
Project Director, Kentucky LEADS Collaborative, Markey Cancer Center

joseph trey alexander

Joseph (Trey) Alexander
Clinical Research Project Manager, Markey Cancer Center Research Network 
Markey Cancer Center is NCI-designated

The UK Markey Cancer Center was first designated by the National Cancer Institute in 2013 – a distinction that recognizes our extraordinary ability to provide world-class care for our patients. We are the only NCI-designated cancer center in Kentucky and one of only 71 in the nation.